According to Charles River Laboratories 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.76444. At the end of 2023 the company had a P/S ratio of 2.94.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.94 | 5.32% |
2022 | 2.79 | -48.09% |
2021 | 5.37 | 26.35% |
2020 | 4.25 | 49.05% |
2019 | 2.85 | 18.44% |
2018 | 2.41 | -13.72% |
2017 | 2.79 | 30.12% |
2016 | 2.14 | -22.12% |
2015 | 2.75 | 18.64% |
2014 | 2.32 | 7.25% |
2013 | 2.16 | 35.29% |
2012 | 1.60 | 35.27% |
2011 | 1.18 | -33.99% |
2010 | 1.79 | -2.93% |
2009 | 1.85 | 39.83% |
2008 | 1.32 | -63.77% |
2007 | 3.64 | 33.22% |
2006 | 2.73 | -2.81% |
2005 | 2.81 | -28.71% |
2004 | 3.95 | 54.05% |
2003 | 2.56 | -18.34% |
2002 | 3.14 | -3.41% |
2001 | 3.25 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 5.30 | 91.80% | ๐บ๐ธ USA |
SCYNEXIS SCYX | 0.7467 | -72.99% | ๐บ๐ธ USA |
Repligen
RGEN | 15.8 | 472.12% | ๐บ๐ธ USA |